The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 540.00
Bid: 538.00
Ask: 542.00
Change: 2.00 (0.37%)
Spread: 4.00 (0.743%)
Open: 527.00
High: 543.00
Low: 527.00
Prev. Close: 538.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AuM Update

10 Oct 2019 07:00

RNS Number : 3525P
Polar Capital Holdings PLC
10 October 2019
 

10 October 2019

 

Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its quarterly update of its unaudited statement of its Assets under Management ("AuM").

 

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 September 2019 its AuM were £14.3bn compared to £13.8bn at the end of March 2019, an increase of 3% over the period. During the period, AuM increased by £467m which comprised net outflows of £448m offset by an increase of £915m related to market movement and fund performance.

 

AuM movement in six months

to 30 September 2019

Long only

funds

Alternative funds

Total

AUM at 1 April 2019

£12,529m

£1,306m

£13,835m

Net subscriptions / (redemptions)

£(560)m

£112m

£(448)m

Market movement and

performance

£868m

£47m

£915m

Total AuM at 30 September 2019

£12,837m

£1,465m

£14,302m

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 18

 

 

Year to

31 Mar 19

(year-end)

 

Six months to

30 Sept 19

 

 

Received

 

£5.5m

£24.0m

£3.3m

Accrued but not yet earned in funds with year ends on or before the financial year end

£27.0m

n/a

£0.9m*

Total net performance fee profits

£32.5m

£24.0m

 

£4.2m*

 

 

*the figures are reduced by £2m of net performance fee distributions that relate to prior accounting periods that IFRS require to be deducted from this year's receipts.

 

 

 

As is usual at the time of releasing this update, three months before the crystallisation of performance fees, we disclose the profits that could be due to Polar as a function of the amount of accrued performance fees in our funds as at the end of September. There is no certainty that the fees will be sustained over the next quarter, as performance fee receipts are extremely volatile.

 

Gavin Rochussen, Chief Executive, commented:

 

"The last quarter has been a challenging period with net outflows of £598m following the £150m of net inflows in the previous quarter.

 

"As communicated at the time of releasing our year-end results in June, the Japan team has undergone changes following the departure of the long-standing manager of our Japan Fund. The team is focused on the Japan Value Fund which has compelling performance and will benefit from greater AuM following the imminent merger of the two funds. Net outflows in the six months from the Japan Fund following the communication of the manager departure and fund merger have been £400m. As at 30 September, the Japanese equities team was managing £314m.

 

"In the six months, two long-standing clients redeemed in excess of £500m from two of our highly rated funds, the Polar Capital Technology Fund and the Polar Capital Healthcare Opportunities Fund to take profits and reduce risk in their underlying client portfolios. This has provided the Technology and Healthcare strategies with additional capacity where the demand for their funds is robust.

 

"Notwithstanding the £900m headwind created by the Japan Fund redemptions and the client redemption from Technology and Healthcare, it is reassuring that, despite the economic and political uncertainty over the last six months, we have had net inflows into the majority of our funds including: Global Insurance, UK Value, European Income and Emerging Market and Asia with positive net inflows of £112m into our alternative fund range which includes our Convertibles and UK Absolute products.

 

"While accrued performance fees are materially less than the previous year, fees are volatile, and the position three months ago was more in line with last year. There are still three months to the end of the calendar year when performance fees crystallise. We remain confident that our active fundamental fund strategies will continue to deliver above average returns over the long term for our clients."

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

Andrew Buchanan

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

Monique Perks

 

 

+44 (0)20 3757 4995

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMLBATMBJMBAL
Date   Source Headline
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares
19th Nov 20192:53 pmRNSForm 8.3 - Consort Medical Plc
11th Nov 201912:08 pmRNSResignation of Non-Executive Director
30th Oct 201912:00 pmRNSNotice of Results
29th Oct 20195:06 pmRNSHolding(s) in Company
22nd Oct 201912:21 pmRNSForm 8.3 - Wincanton PLC
10th Oct 20197:00 amRNSAuM Update
30th Sep 20194:35 pmRNSPrice Monitoring Extension
13th Sep 20192:59 pmRNSForm 8.3 - OneSavings Bank
10th Sep 20192:39 pmRNSForm 8.3 - OneSavings Bank Plc
3rd Sep 201912:26 pmRNSForm 8.3 - OneSavings Bank Plc
2nd Sep 201911:35 amRNSForm 8.3 - easyHotel Plc
23rd Aug 201911:42 amRNSForm 8.3 - OneSavings Bank Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.